Viral hepatitis and liver cancer

Viral hepatitis and liver cancer

Hepatitis B and C viruses are a global health problem causing acute and chronic infections that can lead to liver cirrhosis and hepatocellular carcinoma (HCC). These infections are the leading cause for HCC worldwide and are associated with significant mortality, accounting for more than 1.3 million...

Full description

Bibliographic Details
Main Authors:	Ringehan, M, McKeating, J, Protzer, U
Format:	Journal article
Published:	Royal Society 2017

Similar Items

N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection.
by: Appelman, M, et al.
Published: (2017)

Daytime variation in hepatitis C virus replication kinetics following liver transplant
by: Zhuang, X, et al.
Published: (2018)

Hepatitis C virus infection is associated with hepatic and adipose tissue insulin resistance that improves after viral cure
by: Lim, T, et al.
Published: (2018)

The circadian clock and viral infections
by: Borrmann, H, et al.
Published: (2020)

Unexpected maintenance of hepatitis C viral diversity following liver transplantation.
by: Gray, R, et al.
Published: (2012)

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.
by: Guidotti, L, et al.
Published: (1996)

The role of circadian clock pathways in viral replication
by: Zhuang, X, et al.
Published: (2022)

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.
by: Mendy, M, et al.
Published: (2010)

High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end stage liver disease
by: Hedegaard, D, et al.
Published: (2016)

Synchronised infection identifies early rate‐limiting steps in the hepatitis B virus life cycle
by: Chakraborty, A, et al.
Published: (2020)

Oxygen sensing and viral replication: implications for tropism and pathogenesis
by: Liu, PJ, et al.
Published: (2020)

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner.
by: McKeating, J, et al.
Published: (2004)

Interplay between circadian clock and viral infection
by: Zhuang, X, et al.
Published: (2017)

Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission.
by: Meredith, L, et al.
Published: (2013)

Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease.
by: Lake-Bakaar, G, et al.
Published: (2007)

Regional Hepatic Chemotherapies in the Treatment of Colorectal Cancer Metastases to the Liver
by: Pwint, T, et al.
Published: (2010)

Regional hepatic chemotherapies in the treatment of colorectal cancer metastases to the liver.
by: Pwint, T, et al.
Published: (2010)

The CCCTC-binding factor CTCF represses hepatitis B virus Enhancer I and regulates viral transcription
by: D'Arienzo, V, et al.
Published: (2020)

Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
by: Trivedi, S, et al.
Published: (2017)

Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels
by: Ko, C, et al.
Published: (2018)

Big data in viral hepatitis
by: Campbell, C
Published: (2023)

An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infection
by: Mukherji, A, et al.
Published: (2024)

Liver transplantation for acute hepatic failure?
by: Chapman, R, et al.
Published: (1990)

Estimation of hepatitis B virus cccDNA persistence in chronic infection using within-host evolutionary rates
by: Lythgoe, KA, et al.
Published: (2020)

Metallo supramolecular cylinders inhibit HIV-1 TAR-TAT complex formation and viral replication in cellulo
by: Cardo, L, et al.
Published: (2018)

Hepatic artery chemotherapy and colorectal liver metastases - Reply
by: Kerr, D, et al.
Published: (2003)

TNF superfamily members promote hepatitis C virus entry via an NF-κB and myosin light chain kinase dependent pathway
by: Fletcher, N, et al.
Published: (2017)

The role of virus-specific CD8+cells in liver damage and viral control during persistent hepatitis B virus infection
by: Maini, M, et al.
Published: (2000)

Hepatic iron uptake in alcoholic liver disease.
by: Chapman, R, et al.
Published: (1983)

The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.
by: Maini, M, et al.
Published: (2000)

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens
by: Rogers, Arlin B., et al.
Published: (2010)

Hepatic arterial chemotherapy for colorectal cancer liver metastases: a review of advances in 2003.
by: Chan, R, et al.
Published: (2004)

Hepatic artery chemotherapy and colorectal liver metastases.
by: Brooks, A, et al.
Published: (2003)

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
by: Darby, S, et al.
Published: (1997)

Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK
by: Williams, R, et al.
Published: (2017)

Response to "reconstruction of the hepatic artery in liver transplantation in mice: Mandatory or useless?"
by: Steger, U, et al.
Published: (2004)

Dynamic coinfection with multiple viral subtypes in acute hepatitis C
by: Smith, J, et al.
Published: (2010)

Role of circulating IL-10 in acute viral hepatitis
by: Nebbia, G, et al.
Published: (2006)

Oxygen-dependent histone lysine demethylase 4 restricts hepatitis B virus replication
by: Harris, JM, et al.
Published: (2024)

Computational screening of FDA-approved hepatitis c drugs for inhibition of VEGFR2 in liver cancer
by: Roney, Miah, et al.
Published: (2024)